AstraZeneca Pharma India Limited

BSE
ASTRAZEN
paper.types.company
Rentabilité sur six mois: +39.82%
Rendement en dividendes: 0.2508%

10 524.7 ₹

0 ₹ 0%
6243.05 ₹
10524.65 ₹

paper.min_max_per_year

Calendrier des promotions AstraZeneca Pharma India Limited

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise AstraZeneca Pharma India Limited

AstraZeneca Pharma India Limited, a biopharmaceutical company, engages in manufacturing, distributing, and marketing of pharmaceutical products in India and internationally. It manufactures and sells cardiovascular disease, renal, and metabolism medicines under the CRESTOR, Forxiga, BRILINTA, Xigduo, and Seloken XL brand names; oncology medicines under the TAGRISSO, CALQUENCE, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names. The company also offers medicines for diabetes and immunology diseases. It also provides clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

Paramètres de base

ISIN
INE203A01020
Industry
Pharmaceuticals
Sector
Health Care
Валюта
inr
Валюта отчета
inr
Див.доход ао
0.2508
Дивиденд ао
24
Сайт
lien
Tous les paramètres

Grade

Sous-estimation
Nom Signification Grade
P/S 10.32 1
P/BV 18.77 1
P/E 82.75 1
Efficacité
Nom Signification Grade
ROA 14.98 4
ROE 22.69 7
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0.2508 0.63
DSI 1 10
Croissance moyenne du dividende 13.89 10
Devoir
Nom Signification Grade
Debt/EBITDA 0.0477 10
Debt/Ratio 0.0067 10
Debt/Equity 0.5143 9
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 55.75 7
Rentabilité Ebitda, % 12.95 2
Rentabilité EPS, % 122.91 10
Plus de détails

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 10 524.7 ₹ 0 ₹ 0 ₹ 0 % 0 % 0 %
common.calendar.number_days.7d 10 035.8 ₹ 0 ₹ 0 ₹ 4.87 % 0 % 0 %
common.calendar.number_days.30d 7 972 ₹ 7 965.2 ₹ 10 524.65 ₹ 32.02 % 0 % 0 %
common.calendar.number_days.90d 8 028.85 ₹ 7 839.35 ₹ 10 524.65 ₹ 31.09 % 0 % 0 %
common.calendar.number_days.ytd 7 527.2 ₹ 6 706.4 ₹ 10 524.65 ₹ 39.82 % 0 % 0 %
common.calendar.number_days.1y 6 744.65 ₹ 6 243.05 ₹ 10 524.65 ₹ 56.05 % 0 % 0 %
common.calendar.number_days.3y 3 099.2 ₹ 2 739 ₹ 10 524.65 ₹ 239.59 % 0 % 0 %
common.calendar.number_days.5y 3 344.3 ₹ 2 454.2 ₹ 10 524.65 ₹ 214.71 % 0 % 0 %
common.calendar.number_days.10y 885.75 ₹ 885.75 ₹ 10 524.65 ₹ 1188.22 % 0 % 0 %

Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Pratap Rudra Bhuvanagiri Legal Counsel 3.73M
Ms. Manasa R. Company Secretary & Compliance Officer N/A
Ms. Smita Saha Vice President of Human Resources N/A 1970 (55 années)
Dr. Sanjeev Kumar Panchal MD, Country President & Director 21.15M 1977 (48 années)
Ms. Bhavana Agrawal Whole-Time Director & CFO N/A
Mr. Ayush Kumar Agarwal Interim Business Unit Head of Oncology & Director of Commercial Excellence N/A
Mr. Praveen Akkinepally Head of Oncology Business Unit N/A
Mr. Vinay Sharma Business Unit Head - Rare Disease unit
Mr. Pankaj S Jain Legal Head

Informations sur l'entreprise

Adresse: India, Bengaluru, Manyata Embassy Business Park - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.astrazeneca.in